College of Nursing

Permanent URI for this communityhttps://scholarworks.montana.edu/handle/1/56

The MSU-Bozeman College of Nursing was founded in 1937 and has received continuous national accreditation since 1949. Since its inception, the College has been a multi-campus program, making effective use of educational and clinical resources in the state. The College's administration is located on the main campus of MSU-Bozeman, where most undergraduate students complete lower division nursing requirements. Students move to one of the campuses located in the state's major populations areas, Bozeman, Billings, Great Falls, Kalispell, and Missoula, to complete their upper division course work. With their greater population concentrations, these communities possess health care facilities that provide the degree of complexity, size and diversity of patient population needed for upper division clinical experience. Each of the College's campuses has resident faculty who serve both undergraduate and graduate students.

Browse

Filters

20161

Settings

search.filters.applied.f.department: search.filters.department.Mathematical Sciences.

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Bioenergy and Breast Cancer: A report on tumor growth and metastasis
    (2016) Running, Alice; Greenwood, Mark C.; Hildreth, Laura; Schmidt, Jade
    As many as 80% of the 296,000 women and 2,240 men diagnosed with breast cancer in the United States will seek out complementary and alternative medicine (CAM) treatments. One such therapy is Healing Touch (HT), recognized by the National Center for Complementary and Integrative Health (NCCIH) as a treatment modality. Using a multiple experimental groups design, fifty-six six- to eight-week-old Balb/c mice were injected with 4T1 breast cancer tumor cells and randomly divided into intervention and positive control groups. Five days after tumor cell injection, mice in the intervention groups received HT either daily or every other day for 10 minutes by one HT practitioner. At 15 days after tumor cell injection, tumor size was measured, and metastasis was evaluated by a medical pathologist after necropsy. Tumor size did not differ significantly among the groups (F(3,52) = 0.75, p value = 0.53). The presence of metastasis did not differ across groups (chi-square(3) = 3.902, p = 0.272) or when compared within an organ (liver: chi-square(3) = 2.507, p = 0.474; lungs: chi-square(3) = 3.804, ; spleen: chi-square(3) = 0.595, p = 0.898). However, these results did indicate a moderate, though insignificant, positive impact of HT and highlight the need for continued research into dose, length of treatment, and measurable outcomes (tumor size, metastasis) to provide evidence to suggest application for nursing care.
Copyright (c) 2002-2022, LYRASIS. All rights reserved.